Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Other Operating Expenses (2016 - 2023)

Avricore Health has reported Other Operating Expenses over the past 8 years, most recently at $264125.8 for Q4 2023.

  • Quarterly Other Operating Expenses rose 2.8% to $264125.8 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $264125.8 through Sep 2024, down 71.02% year-over-year, with the annual reading at $889859.5 for FY2024, 19.78% down from the prior year.
  • Other Operating Expenses was $264125.8 for Q4 2023 at Avricore Health, down from $348019.8 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $348019.8 in Q3 2023 and troughed at $151932.3 in Q2 2022.
  • The 3-year median for Other Operating Expenses is $256920.0 (2022), against an average of $249337.8.
  • The largest YoY upside for Other Operating Expenses was 1857.13% in 2019 against a maximum downside of 57.67% in 2019.
  • A 3-year view of Other Operating Expenses shows it stood at $154995.5 in 2019, then skyrocketed by 65.76% to $256920.0 in 2022, then increased by 2.8% to $264125.8 in 2023.
  • Per Business Quant, the three most recent readings for AVCRF's Other Operating Expenses are $264125.8 (Q4 2023), $348019.8 (Q3 2023), and $306589.3 (Q2 2023).